Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods

Li, 2005, Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis, JAMA, 293, 581, 10.1001/jama.293.5.581

Doring, 2000, Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus, Eur Respir J, 16, 749, 10.1034/j.1399-3003.2000.16d30.x

Frederiksen, 1999, Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974–1995), Pediatr Pulmonol, 28, 159, 10.1002/(SICI)1099-0496(199909)28:3<159::AID-PPUL1>3.0.CO;2-1

Koch, 2001, European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations, Pediatr Pulmonol, 31, 1, 10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T

Kosorok, 2001, Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition, Pediatr Pulmonol, 32, 277, 10.1002/ppul.2009.abs

Johansen, 1992, Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark, Thorax, 47, 109, 10.1136/thx.47.2.109

Pedersen, 1987, Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay, J Clin Microbiol, 25, 1830, 10.1128/JCM.25.10.1830-1836.1987

Emerson, 2002, Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis, Pediatr Pulmonol, 34, 91, 10.1002/ppul.10127

Rosenfeld, 1999, Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis, Pediatr Pulmonol, 28, 321, 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V

Tramper-Stranders, 2006, Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population, Thorax, 61, 689, 10.1136/thx.2005.054726

Tramper-Stranders, 2005, Detection of Pseudomonas aeruginosa in patients with cystic fibrosis, J Cyst Fibros, 4, 37, 10.1016/j.jcf.2005.05.009

Høiby, 1977, Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey, Acta Pathol Microbiol Scand Suppl, 262, 1

Granstrom, 1984, Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis, Acta Paediatr Scand, 73, 772, 10.1111/j.1651-2227.1984.tb17774.x

Albus, 1989, Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis, APMIS, 97, 1146, 10.1111/j.1699-0463.1989.tb00531.x

Pressler, 1990, IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA, Clin Exp Immunol, 81, 428, 10.1111/j.1365-2249.1990.tb05351.x

Kronborg, 1992, Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients, J Clin Microbiol., 30, 1848, 10.1128/JCM.30.7.1848-1855.1992

Kappler, 2006, Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis, Thorax, 61, 684, 10.1136/thx.2005.049536

West, 2002, Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors, JAMA, 287, 2958, 10.1001/jama.287.22.2958

Brett, 1990, Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis, Arch Dis Child, 65, 259, 10.1136/adc.65.3.259

Brett, 1992, The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis, Arch Dis Child, 67, 1086, 10.1136/adc.67.9.1086

Pressler, 2006, Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa —a case control study, J Cyst Fibros, 5, 9, 10.1016/j.jcf.2005.11.002

Ratjen, 2007, Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients, Pediatr Pulmonol, 42, 249, 10.1002/ppul.20562

Farrell, 2006, Pseudomonas serology: confusion, controversy, and challenges, Thorax, 61, 645, 10.1136/thx.2006.062612

Lee, 2004, Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center, Pediatr Pulmonol, 37, 104, 10.1002/ppul.10401

Hollsing, 1987, Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis, J Clin Microbiol, 25, 1868, 10.1128/JCM.25.10.1868-1874.1987

Proesmans, 2006, Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre, Eur Respir J, 27, 937, 10.1183/09031936.06.00100805

Frederiksen, 1997, Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis, Pediatr Pulmonol, 23, 330, 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O

Frederiksen, 1996, Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment, Pediatr Pulmonol, 21, 153, 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R

Doring, 1983, Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis, Infect Immun, 42, 197, 10.1128/IAI.42.1.197-201.1983

Brett, 1988, Prediction and diagnosis of early Pseudomonas aeruginosa: a follow-up study, J Clin Microbiol, 26, 1565, 10.1128/JCM.26.8.1565-1570.1988

Corech, 2005, Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis, J Clin Microbiol, 43, 3956, 10.1128/JCM.43.8.3956-3962.2005

Van Delden, 1998, Cell-to-cell signaling and Pseudomonas aeruginosa infections, Emerg Infect Dis, 4, 551, 10.3201/eid0404.980405

Wu, 2000, Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa, Microbiology, 146, 2481, 10.1099/00221287-146-10-2481

Høiby, 1976, The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods, Acta Pathol Microbiol Scand [C], 84C, 372

Doring, 2004, Early intervention and prevention of lung disease in cystic fibrosis: a European consensus, J Cyst Fibros, 3, 67, 10.1016/j.jcf.2004.03.008

Høiby, 1987, Taxonomic application of crossed immunoelectrophoresis, International Journal of Systematic Bacteriology, 37, 229, 10.1099/00207713-37-3-229

Johansen, 1998, Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen, Pediatr Pulmonol, 26, 89, 10.1002/(SICI)1099-0496(199808)26:2<89::AID-PPUL3>3.0.CO;2-C